Dual HER2-blockade with pertuzumab and trastuzumab in HER2-positive early breast cancer: a subanalysis of data from the randomized phase III GeparSepto trial
Titel:
Dual HER2-blockade with pertuzumab and trastuzumab in HER2-positive early breast cancer: a subanalysis of data from the randomized phase III GeparSepto trial
Auteur:
Loibl, S. Jackisch, C. Schneeweiss, A. Schmatloch, S. Aktas, B. Denkert, C. Wiebringhaus, H. Kümmel, S. Warm, M. Paepke, S. Just, M. Hanusch, C. Hackmann, J. Blohmer, J.-U. Clemens, M. Dan Costa, S. Gerber, B. Engels, K. Nekljudova, V. von Minckwitz, G. Untch, M.